🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to evaluate the safety and efficacy of on...
Status
Completed
Location
The Second People's Hospital of Hefei
Start Date
2020-12-07
Trial ID
NCT04591626
Treatments Being Tested
In the Emergency Department (ED), diabetes is commonly encountered as a sec...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00663624
Treatments Being Tested
Primary Objective: Evaluate the percentage of patients achieving glycosyla...
Status
Completed
Location
Administrative office
Start Date
2011-05
Trial ID
NCT01202474
Treatments Being Tested
Primary Objective: To compare the efficacy of insulin glargine (U300) and ...
Status
Completed
Location
Investigational Site Number 1560039
Start Date
2016-08-24
Trial ID
NCT02855684
Treatments Being Tested
Primary objective: To compare long-term glycemic control and preservation ...
Status
Completed
Location
Sanofi-aventis
Start Date
2007-09
Trial ID
NCT00562172
Treatments Being Tested
This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2008-01
Trial ID
NCT00971659
A randomized, split-plot, double-blind, placebo-controlled trial. The varic...
Status
Completed
Location
Mario Aurelio Martínez-Jiménez
Start Date
2019-06-01
Trial ID
NCT04310280
Treatments Being Tested
This trial is conducted in the United States of America (USA). The aim of t...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-01-06
Trial ID
NCT02030600
Treatments Being Tested
This is a pilot study to examine and compare the efficacy of supervised inj...
Status
Completed
Location
Yale University
Start Date
2017-10-01
Trial ID
NCT03400501
Treatments Being Tested
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Status
Unknown
Location
Servizio di Diabetologia UOC Medicina Generale
Start Date
2018-12-19
Trial ID
NCT03959865